\BOOKMARK [0][-]{chapter*.3}{References}{}% 176
\BOOKMARK [0][-]{appendix.A}{Sample Quality}{}% 177
\BOOKMARK [1][-]{section.A.1}{Sample Correlation}{appendix.A}% 178
\BOOKMARK [1][-]{section.A.2}{Replicate Samples in TCGA Breast}{appendix.A}% 179
\BOOKMARK [0][-]{appendix.B}{Software Used for Thesis}{}% 180
\BOOKMARK [0][-]{appendix.C}{Secondary Screen Data}{}% 181
\BOOKMARK [0][-]{appendix.D}{Mutation Analysis in Breast Cancer}{}% 182
\BOOKMARK [1][-]{section.D.1}{Synthetic Lethal Genes and Pathways}{appendix.D}% 183
\BOOKMARK [1][-]{section.D.2}{Synthetic Lethal Expression Profiles}{appendix.D}% 184
\BOOKMARK [1][-]{section.D.3}{Comparison to Primary Screen}{appendix.D}% 185
\BOOKMARK [2][-]{subsection.D.3.1}{Resampling Analysis}{section.D.3}% 186
\BOOKMARK [1][-]{section.D.4}{Compare SLIPT genes}{appendix.D}% 187
\BOOKMARK [1][-]{section.D.5}{Metagene Analysis}{appendix.D}% 188
\BOOKMARK [1][-]{section.D.6}{Mutation Variation}{appendix.D}% 189
\BOOKMARK [2][-]{subsection.D.6.1}{Mutation Frequency}{section.D.6}% 190
\BOOKMARK [2][-]{subsection.D.6.2}{PI3K Mutation Expression}{section.D.6}% 191
\BOOKMARK [0][-]{appendix.E}{Metagene Expression Profiles}{}% 192
\BOOKMARK [0][-]{appendix.F}{Stomach Expression Analysis}{}% 193
\BOOKMARK [1][-]{section.F.1}{Synthetic Lethal Genes and Pathways}{appendix.F}% 194
\BOOKMARK [1][-]{section.F.2}{Comparison to Primary Screen}{appendix.F}% 195
\BOOKMARK [2][-]{subsection.F.2.1}{Resampling Analysis}{section.F.2}% 196
\BOOKMARK [1][-]{section.F.3}{Metagene Analysis}{appendix.F}% 197
\BOOKMARK [0][-]{appendix.G}{Stomach Mutation Analysis}{}% 198
\BOOKMARK [1][-]{section.G.1}{Synthetic Lethal Genes and Pathways}{appendix.G}% 199
\BOOKMARK [1][-]{section.G.2}{Synthetic Lethal Expression Profiles}{appendix.G}% 200
\BOOKMARK [1][-]{section.G.3}{Comparison to Primary Screen}{appendix.G}% 201
\BOOKMARK [2][-]{subsection.G.3.1}{Resampling Analysis}{section.G.3}% 202
\BOOKMARK [1][-]{section.G.4}{Metagene Analysis}{appendix.G}% 203
\BOOKMARK [0][-]{appendix.H}{Global Synthetic Lethality in Stomach Cancer}{}% 204
\BOOKMARK [1][-]{section.H.1}{Hub Genes}{appendix.H}% 205
\BOOKMARK [1][-]{section.H.2}{Hub Pathways}{appendix.H}% 206
\BOOKMARK [0][-]{appendix.I}{Replication in cell line encyclopaedia}{}% 207
\BOOKMARK [0][-]{appendix.J}{Synthetic Lethal Genes in Pathways}{}% 208
